Itafos Inc. (TSX-V: IFOS) (the “Company”) reported today its Q3
2023 financial and operational highlights. The Company’s financial
statements and management’s discussion and analysis for the three
and nine months ended September 30, 2023 are available under the
Company’s profile at www.sedarplus.com and on the Company’s website
at www.itafos.com. All figures are in thousands of US Dollars
except as otherwise noted.
CEO Commentary
“We are pleased to report solid financial
results and the continuation of our strong safety and operational
performance in Q3 2023. For the nine months ending September 30,
2023, we reported revenues of $346.5 million and adjusted EBITDA of
$102.3 million.
During the third quarter, we continued to
successfully execute our business plan and made significant
progress on a number of key company objectives. Work
intensified and continues on our Husky 1 / North Dry Ridge
(“H1/NDR”) capital project with the project remaining on budget and
on schedule for 2026 operations. Additionally, the Company
entered into a new five-year monoammonium phosphate sales agreement
(the “MAP Offtake Agreement”) with J. R. Simplot Company, an
international food and agriculture company. The agreement, which
commences on January 1, 2024, provides visibility around our MAP
sales volumes over the medium term.
During Q3 2023, we saw prices rebound and
moderate off the lows of Q2 2023, reflective of demand improvement
and tighter US supply fundamentals. We expect to see these
conditions continue into 1H of 2024. The Company has maintained its
full year EBITDA guidance (narrowing the bottom of the range),
based off these improved market conditions.
Finally, the process to explore and evaluate
various strategic alternatives to enhance value for all Itafos
shareholders announced by our Board in Q1 2023 continues.” said G.
David Delaney, CEO of Itafos.
Q3 2023 Key Highlights
- revenues of $110.8 million
- Adjusted EBITDA of $19.7 million1
- net income of $3.1 million
- basic earnings of C$0.02/share
- free cash flow of $(9.7) million1
9M 2023 Key Highlights
- revenues of $ 346.5 million
- Adjusted EBITDA of $ 102.3 million
- net income of $ 51.7 million
- basic earnings of C$ 0.37/share
- free cash flow of $ 54.2 million
September 30, 2023 Key
Highlights
- trailing 12 months Adjusted EBITDA of $ 152.4 million1
- net debt of $ 62.9 million1
- net leverage ratio of 0.4x1
Narrowed FY 2023 Guidance
- Adjusted EBITDA guidance of $125-135 million
- net income guidance of $50-60 million
- basic earnings guidance of C$0.34-0.41/share
- maintenance capex guidance of $15-25 million1
- growth capex guidance of $35-45 million1
- free cash flow guidance of $65-85 million
Q3 and 9M 2023 Market
Highlights
Diammonium phosphate (“DAP”) New Orleans
(“NOLA”) prices averaged $507/st in Q3 2023 compared to $761/st in
Q3 2022, down 33% year-over-year, and averaged $550/st in 9M 2023
compared to $805/st in 9M 2022, down 32% year-over-year. Specific
factors driving the year-over-year decline in DAP NOLA were as
follows:
- weakened demand in response to historically high 2022 phosphate
prices;
- the softening of global ammonia and sulfur prices;
- the softening of historically high crop prices; and
- increased phosphate exports out of Russia and China.
Q3 2023 Financial
Highlights
For Q3 2023, the Company’s financial highlights
were as follows:
- revenues of $110.8 million in Q3 2023 compared to $153.2
million in Q3 2022;
- Adjusted EBITDA of $19.7 million in Q3 2023 compared to $50.7
million in Q3 2022;
- net income of $3.1 million in Q3 2023 compared to $8.1 million
in Q3 2022;
- basic earnings of C$0.02/share in Q3 2023 compared to
C$0.06/share in Q3 2022; and
- free cash flow of $(9.7) million in Q3 2023 compared to $53.6
million in Q3 2022.
The decrease in the Company’s Q3 2023 financial
performance compared to Q3 2022 was primarily due to lower realized
prices as a result of softer global market conditions partially
offset by higher sales volumes and lower input costs.
The Company’s total capex2 spend in Q3 2023 was
$16.3 million compared to $8.7 million in Q3 2022 with the increase
primarily due to the development activities at H1/NDR at Conda.
9M 2023 Financial
Highlights
For 9M 2023, the Company’s financial highlights
were as follows:
- revenues of $346.5 million in 9M 2023 compared to $458.0
million in 9M 2022;
- Adjusted EBITDA of $102.3 million in 9M 2023 compared to $174.6
million in 9M 2022;
- net income of $51.7 million in 9M 2023 compared to $85.4
million in 9M 2022;
- basic earnings of C$0.37/share in 9M 2023 compared to
C$0.58/share in 9M 2022; and
- free cash flow of $54.2 million in 9M 2023 compared to $149.2
million in 9M 2022.
The decrease in the Company’s 9M 2023 financial
performance compared to 9M 2022 was primarily due to lower realized
prices, partially offset by lower input costs.
The Company’s total capex2 spend in 9M 2023 was
$37.2 million compared to $30.0 million in 9M 2022 with the
increase primarily due to development activities at H1/NDR at
Conda
September 30, 2023
Highlights
As at September 30, 2023, the Company had
trailing 12 months Adjusted EBITDA of $152.4 million compared to
$224.8 million at the end of 2022 with the decrease primarily due
to the same factors that resulted in lower revenues, which were
partially offset by lower input costs at Conda.
At September 30, 2023, the Company had net debt
of $62.9 million compared to $88.3 million at the end of 2022, with
the reduction due to the repayment of principal debt outstanding
from free cash flows generated, which was partially offset by lower
cash and cash equivalents. The Company’s net debt as at September
30, 2023 was comprised of $36.4 million in cash and $97.8 million
in debt (gross of deferred financing costs). As at September 30,
2023 and the end of 2022, the Company’s net leverage ratio was
0.4x
As at September 30, 2023, the Company had
liquidity3 of $76.4 million comprised of $36.4 million in cash and
$40.0 million in undrawn borrowing capacity under its $80 million
asset-based revolving credit facility (the “ABL Facility”).
Q3 2023 Operational
Highlights
Environmental, Health, and Safety (“EHS”)
- Sustained EHS performance, including no reportable
environmental releases and two recordable incidents, which resulted
in a consolidated total recordable incident frequency rate
(“TRIFR”) of 0.58.
Conda
- Produced 87,976 tonnes P2O5 at Conda in Q3 2023 compared to
84,908 tonnes P2O5 in Q3 2022 with the increase primarily due to
higher throughput resulting from reduced downtime;
- Generated revenues of $106.8 million at Conda in Q3 2023
compared to $145.3 million in Q3 2022 with the decrease primarily
due to lower realized selling prices, which were partially offset
by higher sales volumes. Elevated prices in the prior year driven
primarily by the Russian invasion of Ukraine and the three-month
lagged pricing impact on Conda’s MAP contract;
- Generated Adjusted EBITDA at Conda of $23.7 million in Q3 2023
compared to $54.2 million in Q3 2022 with the decrease primarily
due to the same factors that resulted in lower revenues, which were
partially offset by lower input costs.
- Advanced H1/NDR capital activities including earthworks and
related water management features for the rail loadout and haul
road, improvement of the maintenance shop, and existing road
relocation;
- On September 7, 2023, the Company announced that it entered
into the MAP Offtake Agreement with J.R. Simplot Company, an
international food and agriculture company. The Company will sell
100% of the MAP produced by Conda to the J.R. Simplot Company
during the term of the MAP Offtake Agreement, which will commence
on January 1, 2024, with a term of five years. The MAP Offtake
Agreement will replace the existing MAP sales agreement dated
January 12, 2018, between the Company and Nutrien Ltd. (“Nutrien”),
which is set to expire on December 31, 2023; and
- On September 7, 2023, the Company entered into a new ammonia
supply contract with a subsidiary of Nutrien, which will commence
on January 1, 2024, with a term of two years. The new ammonia
supply contract will replace the current supply contract dated
January 12, 2018, between the Company and Nutrien, which is set to
expire on December 31, 2023.
Q3 2023 Other Highlights
- Produced 25,851 tonnes of sulfuric acid at Arraias in Q3 2023
compared to 32,935 tonnes in Q3 2022 with the decrease primarily
due to sulfuric acid lower demand in Q3 2023;
- Produced 4,553 tonnes P2O5 of Direct Application Phosphate Rock
(“DAPR”) at Arraias in Q3 2023 compared to 0 tonnes P2O5 in Q3 2022
with the increase due to the first full quarter of DAPR production
and sales per Fertilizer Restart Program; and
- Generated Adjusted EBITDA at Arraias of $0.1 million loss in Q3
2023 compared to $0.2 million gain in Q3 2022 with the decrease
primarily due to lower realized sulfuric acid prices, which were
partially offset by lower cost of goods sold and commencement of
DAPR sales.
9M 2023 Operational
Highlights
EHS
- Sustained EHS performance, including no reportable
environmental releases and four recordable incidents, which
resulted in a consolidated TRIFR of 0.58.
Conda
- Produced 253,311 tonnes P2O5 at Conda in Q3 2023 compared to
254,300 tonnes P2O5 in Q3 2022;
- Generated revenues of $335.7 million at Conda in Q3 2023
compared to $441.7 million in Q3 2022 with the decrease primarily
due to lower realized selling prices;
- Generated Adjusted EBITDA at Conda of $115.8 million in Q3 2023
compared to $185.3 million in Q3 2022 with the decrease primarily
due to the same factors that resulted in lower revenues, which were
partially offset by lower input costs;
- On April 24, 2023, the Company announced the Record of Decision
for the H1/NDR mine development project. The H1/NDR project
comprises primarily of civil activities and infrastructure
development. Mineral resources from H1/NDR are expected from 20264
onward, providing an uninterrupted supply as Rasmussen Valley Mine
reaches the end of its useful life;
- On May 8, 2023, the Company received the Notice to Proceed
(“NTP”) for the H1/NDR mine development project. Upon receipt of
the NTP, the Company commenced capital activities associated with
the mine development project;
- Advanced H1/NDR capital activities including earthworks and
related water management features for the rail loadout and haul
road, improvement of the maintenance shop, and existing road
relocation;
- Advanced development, including engineering of key
infrastructure and progression of related magnesium oxide reduction
initiatives to enhance SPA production and sales volumes, including
continuation of test work;
- On September 7, 2023, the Company announced that it entered
into the MAP Offtake Agreement with J.R. Simplot Company, an
international food and agriculture company. The Company will sell
100% of the MAP produced by Conda to J.R. Simplot Company during
the term of the MAP Offtake Agreement, which will commence on
January 1, 2024, with a term of five years. The MAP Offtake
Agreement will replace the existing MAP sales agreement dated
January 12, 2018, between the Company and Nutrien, which is set to
expire on December 31, 2023; and
- On September 7, 2023, the Company entered into a new ammonia
supply contract with a subsidiary of Nutrien, which will commence
on January 1, 2024, with a term of two years. The new ammonia
supply contract will replace the current supply contract dated
January 12, 2018, between the Company and Nutrien, which is set to
expire on December 31, 2023.
9M 2023 Other Highlights
- Produced 54,988 tonnes of sulfuric acid at Arraias in 9M 2023
compared to 63,135 tonnes in 9M 2022 with the decrease due to the
sulfuric acid plant shutdown for required maintenance in April and
May;
- Produced 4,553 tonnes P2O5 of DAPR at Arraias in 9M 2023
compared to 0 tonnes P2O5 in 9M 2022 with the increase due to the
first full quarter of DAPR production and sales per Fertilizer
Restart Program;
- Generated Adjusted EBITDA at Arraias of $0.7 million loss in 9M
2023 compared to $0.1 million loss in 9M 2022 with the decrease
primarily due to lower realized sulfuric acid prices, which were
partially offset by higher sales volumes and lower cost of goods
sold and selling, general and administrative expenses;
- On June 28, 2023, the Company filed the NI 43-101 technical
report for the Farim Phosphate Project; and
- The Special Committee of the Board of Directors continues to
evaluate strategic alternatives that may be available to Company in
an effort to enhance shareholder value.
Market Outlook
Prices in 2023 have moderated off the
historically high prices in 2022, which continued to drive a
reduction in Q3 2023 prices. Due to the nature of our MAP sales
contract, with sales price determined by a three-month lagging
average, the impact of this decrease, coupled with lower SPA reset
pricing, impacted the Company’s performance in Q3 2023. Through Q3
and now into Q4 2023, the Company has seen robust demand return to
the market, resulting in improved pricing and tightened North
American phosphate fertilizer supply, which is expected to remain
through the first half of next year.
Specific factors the Company expects to support
strength in the global phosphate fertilizer markets through the end
of 2023 are as follows:
- no significant phosphate supply capacity additions;
- strong demand for phosphates in North America following years
of under application;
- exceptional farmer affordability due to higher crop
prices; and
- ongoing phosphate export restrictions from China and reduced
exports from Morocco.
Financial Outlook
The Company narrowed its guidance for 2023 as
follows:
(in millions of US Dollars |
|
Projected |
except
as otherwise noted) |
|
FY 2023 |
Adjusted EBITDA |
$ |
125-135 |
Net income |
|
50-60 |
Basic earnings (C$/share) |
|
0.34-0.41 |
Maintenance capex |
|
15-25 |
Growth capex |
|
35-45 |
Free cash flow |
|
65-85 |
Business Outlook
The Company continues to focus on the following
key objectives to drive long-term value and shareholder
returns:
- improving financial and operational performance;
- deleveraging its balance sheet;
- executing on the requisite infrastructure and civil works
required for the mine development for H1/NDR; and
- conducting the strategic review process (including evaluating
potential strategic alternatives for the Company as outlined in the
news release dated March 13, 2023).
About Itafos
The Company is a phosphate and specialty
fertilizer company. The Company’s businesses and projects are as
follows:
- Conda – a vertically integrated phosphate fertilizer business
located in Idaho, US with production capacity as follows:
- approximately 550kt per year of monoammonium phosphate (“MAP”),
MAP with micronutrients (“MAP+”), superphosphoric acid (“SPA”),
merchant grade phosphoric acid (“MGA”) and ammonium polyphosphate
(“APP”); and
- approximately 27kt per year of hydrofluorosilicic acid
(“HFSA”);
- Arraias – a vertically integrated phosphate fertilizer business
located in Tocantins, Brazil with production capacity as follows:
- approximately 500kt per year of single superphosphate (“SSP”)
and SSP with micronutrients (“SSP+”); and
- approximately 40kt per year of excess sulfuric acid (220kt per
year gross sulfuric acid production capacity);
- Farim – a high-grade phosphate mine project located in Farim,
Guinea-Bissau;
- Santana – a vertically integrated high-grade phosphate mine and
fertilizer plant project located in Pará, Brazil; and
- Araxá – a vertically integrated rare earth elements and niobium
mine and extraction plant project located in Minas Gerais,
Brazil.
As at September 30, 2023, the Company has
completed the wind down process of the Mantaro mine project
(located in Junin, Peru).
The Company is a Delaware corporation that is
headquartered in Houston, TX. The Company’s shares trade on the TSX
Venture Exchange (“TSX-V”) under the ticker symbol “IFOS”. The
Company’s principal shareholder is CL Fertilizers Holding LLC
(“CLF”). CLF is an affiliate of Castlelake, L.P., a global private
investment firm.
For more information, or to join the Company’s
mailing list to receive notification of future news releases,
please visit the Company’s website at www.itafos.com.
Forward-Looking Information
Certain information contained in this news
release constitutes forward-looking information, including
statements with respect to: the timing for commencement of
operations at H1 / NDR; the expected resource life of H1 / NDR; the
sources of funding to be used for the development of H1 / NDR; and
economic and market trends with respect to the global agriculture
and phosphate fertilizer markets. All information other than
information of historical fact is forward-looking information.
Statements that address activities, events or developments that the
Company believes, expects or anticipates will or may occur in the
future include, but are not limited to, statements regarding
estimates and/or assumptions in respect of the Company’s financial
and business outlook are forward-looking information. The use of
any of the words “intend”, “anticipate”, “plan”, “continue”,
“estimate”, “expect”, “may”, “will”, “project”, “should”, “would”,
“believe”, “predict” and “potential” and similar expressions are
intended to identify forward-looking information.
The forward-looking information contained in
this news release is based on the opinions, assumptions and
estimates of management set out herein, which management believes
are reasonable as at the date the statements are made. Those
opinions, assumptions and estimates are inherently subject to a
variety of risks and uncertainties and other known and unknown
factors that could cause actual events or results to differ
materially from those projected in the forward-looking information.
These include the Company’s expectations and assumptions with
respect to the following: commodity prices; operating results;
safety risks; changes to the Company’s mineral reserves and
resources; risk that timing of expected permitting will not be met;
changes to mine development and completion; foreign operations
risks; changes to regulation; environmental risks; the impact of
adverse weather and climate change; general economic changes,
including inflation and foreign exchange rates; the actions of the
Company’s competitors and counterparties; financing, liquidity,
credit and capital risks; the loss of key personnel; impairment
risks; cybersecurity risks; risks relating to transportation and
infrastructure; changes to equipment and suppliers; adverse
litigation; changes to permitting and licensing; geo-political
risks; loss of land title and access rights; changes to insurance
and uninsured risks; the potential for malicious acts; market
volatility; changes to technology; changes to tax laws; the risk of
operating in foreign jurisdictions; and the risks posed by a
controlling shareholder and other conflicts of interest. Readers
are cautioned that the foregoing list of risks, uncertainties and
assumptions is not exhaustive.
Although the Company has attempted to identify
crucial factors that could cause actual actions, events or results
to differ materially from those described in forward-looking
information, there may be other factors that cause actions, events
or results not to be as anticipated, estimated or intended.
Additional risks and uncertainties affecting the forward-looking
information contained in this news release are described in greater
detail in the Company’s current Annual Information Form and current
Management’s Discussion and Analysis available under the Company’s
profile on SEDAR+ at www.sedarplus.com and on the Company’s website
at www.itafos.com. There can be no assurance that forward-looking
information will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
information. The reader is cautioned not to place undue reliance on
forward-looking information. The Company undertakes no obligation
to update forward-looking statements if circumstances or
management’s estimates, assumptions or opinions should change,
except as required by applicable securities law. The
forward-looking information included in this news release is
expressly qualified by this cautionary statement and is made as of
the date of this news release.
This news release contains future-oriented
financial information and financial outlook information (together,
“FOFI”) about the Company’s prospective results of operations,
including statements regarding expected adjusted EBITDA, net
income, basic earnings per share, maintenance capex, growth capex
and free cash flow. FOFI is subject to the same assumptions, risk
factors, limitations and qualifications as set forth in the above
paragraph. The Company has included the FOFI to provide an outlook
of management’s expectations regarding anticipated activities and
results, and such information may not be appropriate for other
purposes. The Company and management believe that the FOFI has been
prepared on a reasonable basis, reflecting management’s reasonable
estimates and judgements; however, actual results of operations and
the resulting financial results may vary from the amounts set forth
herein. Any financial outlook information speaks only as of the
date on which it is made and the Company undertakes no obligation
to publicly update or revise any financial outlook information
except as required by applicable securities laws.
NEITHER THE TSX-V NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX-V)
ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS
RELEASE.
For further information, please
contact:
Matthew O’NeillItafos Investor
Relationsinvestor@itafos.com713-242-8446
Scientific and Technical
Information
The scientific and technical information
contained in this news release related to Mineral Resources for
Conda and Farim has been reviewed and approved by Jerry DeWolfe,
Professional Geologist (P.Geo.) with the Association of
Professional Engineers and Geoscientists of Alberta. Mr. DeWolfe is
a full-time employee of WSP Canada Inc. and is independent of the
Company. The scientific and technical information contained in this
news release related to Mineral Reserves for Conda and Farim has
been reviewed and approved by Edward Minnes, Professional Engineer
(P.E.) licensed by the State of Missouri. Mr. Minnes is a part-time
employee of WSP USA Inc. and is independent of the Company. The
Company’s latest technical report in respect of Conda is entitled,
“NI 43-101 Technical Report on Itafos Conda and Paris Hills Mineral
Projects, Idaho, USA,” with an effective date of July 1, 2019 (the
“Conda Technical Report”) and is available under the Company’s
website at www.itafos.com and under the Company’s profile on SEDAR+
at www.sedarplus.com
Non-IFRS Financial Measures
This press release contains both IFRS and
certain non-IFRS measures that management considers to evaluate the
Company’s operational and financial performance. Non-IFRS measures
are a numerical measure of a company’s performance, that either
include or exclude amounts that are not normally included or
excluded from the most directly comparable IFRS measures.
Management believes that the non-IFRS measures provide useful
supplemental information to investors, analysts, lenders and
others. In evaluating non-IFRS measures, investors, analysts,
lenders and others should consider that non-IFRS measures do not
have any standardized meaning under IFRS and that the methodology
applied by the Company in calculating such non-IFRS measures may
differ among companies and analysts. Non-IFRS measures should not
be considered as a substitute for, nor superior to, measures of
financial performance prepared in accordance with IFRS. Definitions
and reconciliations of non-IFRS measures to the most directly
comparable IFRS measures are included below.
DEFINITIONS
The Company defines its non-IFRS measures as
follows:
Non-IFRS measure |
Definition |
Most directly comparable IFRS measure |
Why the Company uses the measure |
EBITDA |
Earnings before interest, taxes, depreciation, depletion and
amortization |
Net income (loss) and operating income (loss) |
EBITDA is a valuable indicator of the Company’s ability to generate
operating income |
Adjusted EBITDA |
EBITDA adjusted for non-cash, extraordinary, non-recurring and
other items unrelated to the Company’s core operating
activities |
Net income (loss) and operating income (loss) |
Adjusted EBITDA is a valuable indicator of the Company’s ability to
generate operating income from its core operating activities
normalized to remove the impact of non-cash, extraordinary and
non-recurring items. The Company provides guidance on Adjusted
EBITDA as useful supplemental information to investors, analysts,
lenders, and others |
Trailing 12 months Adjusted EBITDA |
Adjusted EBITDA for the current and preceding three quarters |
Net income (loss) and operating income (loss) for the current and
preceding three quarters |
The Company uses the trailing 12 months Adjusted EBITDA in the
calculation of the net leverage ratio (non-IFRS measure) |
Total capex |
Additions to property, plant, and equipment and mineral properties
adjusted for additions to asset retirement obligations, additions
to right-of-use assets and capitalized interest |
Additions to property, plant and equipment and mineral
properties |
The Company uses total capex in the calculation of total cash capex
(non-IFRS measure) |
Maintenance capex |
Portion of total capex relating to the maintenance of ongoing
operations |
Additions to property, plant and equipment and mineral
properties |
Maintenance capex is a valuable indicator of the Company’s required
capital expenditures to sustain operations at existing levels |
Growth capex |
Portion of total capex relating to the development of growth
opportunities |
Additions to property, plant and equipment and mineral
properties |
Growth capex is a valuable indicator of the Company’s capital
expenditures related to growth opportunities. |
Net debt |
Debt less cash and cash equivalents plus deferred financing costs
(does not consider lease liabilities) |
Current debt, long-term debt and cash and cash equivalents |
Net debt is a valuable indicator of the Company’s net debt position
as it removes the impact of deferring financing costs. |
Net leverage ratio |
Net debt divided by trailing 12 months Adjusted EBITDA |
Current debt, long-term debt and cash and cash equivalents; net
income (loss) and operating income (loss) for the current and
preceding three quarters |
The Company’s net leverage ratio is a valuable indicator of its
ability to service its debt from its core operating
activities. |
Liquidity |
Cash and cash equivalents plus undrawn committed borrowing
capacity |
Cash and cash equivalents |
Liquidity is a valuable indicator of the Company’s liquidity |
Free cash flow |
Cash flows from operating activities, which excludes payment of
interest expense, plus cash flows from investing activities less
cash growth capex |
Cash flows from operating activities and cash flows from investing
activities |
Free cash flow is a valuable indicator of the Company’s ability to
generate cash flows from operations after giving effect to required
capital expenditures to sustain operations at existing levels. Free
cash flow is a valuable indicator of the Company’s cash flow
available for debt service or to fund growth opportunities. The
Company provides guidance on free cash flow as useful supplemental
information to investors, analysts, lenders, and others. |
EBITDA, ADJUSTED EBITDA AND TRAILING 12
MONTHS ADJUSTED EBITDA
For the three months ended September 30,
2023 and 2022
For the three months ended September 30, 2023,
the Company had EBITDA and Adjusted EBITDA by segment as
follows:
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Net income (loss) |
|
$ |
9,790 |
|
|
$ |
(1,235 |
) |
|
$ |
(192 |
) |
|
$ |
(5,285 |
) |
|
$ |
3,078 |
|
Finance (income) expense,
net |
|
|
1,423 |
|
|
|
(204 |
) |
|
|
— |
|
|
|
3,088 |
|
|
|
4,307 |
|
Current and deferred income tax
expense (recovery) |
|
|
1,878 |
|
|
|
— |
|
|
|
— |
|
|
|
(2,289 |
) |
|
|
(411 |
) |
Depreciation and depletion |
|
|
10,630 |
|
|
|
681 |
|
|
|
6 |
|
|
|
40 |
|
|
|
11,357 |
|
EBITDA |
|
$ |
23,721 |
|
|
$ |
(758 |
) |
|
$ |
(186 |
) |
|
$ |
(4,446 |
) |
|
$ |
18,331 |
|
Unrealized foreign exchange
(gain) loss |
|
|
— |
|
|
|
672 |
|
|
|
(68 |
) |
|
|
— |
|
|
|
604 |
|
Share-based payment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
223 |
|
|
|
223 |
|
Transaction costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
488 |
|
|
|
488 |
|
Other expense, net |
|
|
— |
|
|
|
6 |
|
|
|
3 |
|
|
|
— |
|
|
|
9 |
|
Adjusted EBITDA |
|
$ |
23,721 |
|
|
$ |
(80 |
) |
|
$ |
(251 |
) |
|
$ |
(3,735 |
) |
|
$ |
19,655 |
|
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Operating income (loss) |
|
$ |
13,094 |
|
|
$ |
(761 |
) |
|
$ |
(257 |
) |
|
$ |
(4,487 |
) |
|
$ |
7,589 |
|
Depreciation and depletion |
|
|
10,630 |
|
|
|
681 |
|
|
|
6 |
|
|
|
40 |
|
|
|
11,357 |
|
Realized foreign exchange
gain |
|
|
(3 |
) |
|
|
— |
|
|
|
— |
|
|
|
1 |
|
|
|
(2 |
) |
Share-based payment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
223 |
|
|
|
223 |
|
Transaction costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
488 |
|
|
|
488 |
|
Adjusted EBITDA |
|
$ |
23,721 |
|
|
$ |
(80 |
) |
|
$ |
(251 |
) |
|
$ |
(3,735 |
) |
|
$ |
19,655 |
|
For the three months ended September 30, 2022,
the Company had EBITDA and Adjusted EBITDA by segment as
follows:
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Net income (loss) |
|
$ |
29,564 |
|
|
$ |
(684 |
) |
|
$ |
151 |
|
|
$ |
(20,943 |
) |
|
$ |
8,088 |
|
Finance (income) expense,
net |
|
|
1,422 |
|
|
|
(52 |
) |
|
|
— |
|
|
|
21,393 |
|
|
|
22,763 |
|
Current and deferred income tax
expense (recovery) |
|
|
14,550 |
|
|
|
— |
|
|
|
— |
|
|
|
(4,437 |
) |
|
|
10,113 |
|
Depreciation and depletion |
|
|
8,706 |
|
|
|
546 |
|
|
|
4 |
|
|
|
46 |
|
|
|
9,302 |
|
EBITDA |
|
$ |
54,242 |
|
|
$ |
(190 |
) |
|
$ |
155 |
|
|
$ |
(3,941 |
) |
|
|
50,266 |
|
Unrealized foreign exchange
(gain) loss |
|
|
— |
|
|
|
652 |
|
|
|
(427 |
) |
|
|
408 |
|
|
|
633 |
|
Share-based payment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
252 |
|
|
|
252 |
|
Transaction costs |
|
|
— |
|
|
|
— |
|
|
|
60 |
|
|
|
300 |
|
|
|
360 |
|
Other (income) expense, net |
|
|
— |
|
|
|
(280 |
) |
|
|
2 |
|
|
|
(577 |
) |
|
|
(855 |
) |
Adjusted EBITDA |
|
$ |
54,242 |
|
|
$ |
182 |
|
|
$ |
(210 |
) |
|
$ |
(3,558 |
) |
|
$ |
50,656 |
|
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Operating income (loss) |
|
$ |
45,589 |
|
|
$ |
(364 |
) |
|
$ |
(274 |
) |
|
$ |
(4,163 |
) |
|
$ |
40,788 |
|
Depreciation and depletion |
|
|
8,706 |
|
|
|
546 |
|
|
|
4 |
|
|
|
46 |
|
|
|
9,302 |
|
Realized foreign exchange
gain |
|
|
(53 |
) |
|
|
— |
|
|
|
— |
|
|
|
7 |
|
|
|
(46 |
) |
Share-based payment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
252 |
|
|
|
252 |
|
Transaction costs |
|
|
— |
|
|
|
— |
|
|
|
60 |
|
|
|
300 |
|
|
|
360 |
|
Adjusted EBITDA |
|
$ |
54,242 |
|
|
$ |
182 |
|
|
$ |
(210 |
) |
|
$ |
(3,558 |
) |
|
$ |
50,656 |
|
For the nine months ended
September 30, 2023 and 2022
For the nine months ended September 30,
2023, the Company had EBITDA and Adjusted EBITDA by segment as
follows:
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Net income (loss) |
|
$ |
64,973 |
|
|
$ |
(2,407 |
) |
|
$ |
(977 |
) |
|
$ |
(9,874 |
) |
|
$ |
51,715 |
|
Finance (income) expense,
net |
|
|
4,703 |
|
|
|
(475 |
) |
|
|
79 |
|
|
|
10,434 |
|
|
|
14,741 |
|
Current and deferred income tax
expense (recovery) |
|
|
18,894 |
|
|
|
— |
|
|
|
— |
|
|
|
(17,159 |
) |
|
|
1,735 |
|
Depreciation and depletion |
|
|
27,212 |
|
|
|
2,094 |
|
|
|
11 |
|
|
|
135 |
|
|
|
29,452 |
|
EBITDA |
|
$ |
115,782 |
|
|
$ |
(788 |
) |
|
$ |
(887 |
) |
|
$ |
(16,464 |
) |
|
$ |
97,643 |
|
Unrealized foreign exchange
loss |
|
|
— |
|
|
|
164 |
|
|
|
131 |
|
|
|
— |
|
|
|
295 |
|
Share-based payment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,825 |
|
|
|
2,825 |
|
Transaction costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,652 |
|
|
|
1,652 |
|
Other income, net |
|
|
(24 |
) |
|
|
(69 |
) |
|
|
(29 |
) |
|
|
— |
|
|
|
(122 |
) |
Adjusted EBITDA |
|
$ |
115,758 |
|
|
$ |
(693 |
) |
|
$ |
(785 |
) |
|
$ |
(11,987 |
) |
|
$ |
102,293 |
|
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Operating income (loss) |
|
$ |
88,539 |
|
|
$ |
(2,787 |
) |
|
$ |
(796 |
) |
|
$ |
(16,601 |
) |
|
$ |
68,355 |
|
Depreciation and depletion |
|
|
27,212 |
|
|
|
2,094 |
|
|
|
11 |
|
|
|
135 |
|
|
|
29,452 |
|
Realized foreign exchange
loss |
|
|
7 |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
|
|
9 |
|
Share-based payment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,825 |
|
|
|
2,825 |
|
Transaction costs |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,652 |
|
|
|
1,652 |
|
Adjusted EBITDA |
|
$ |
115,758 |
|
|
$ |
(693 |
) |
|
$ |
(785 |
) |
|
$ |
(11,987 |
) |
|
$ |
102,293 |
|
For the nine months ended September 30,
2022, the Company had EBITDA and Adjusted EBITDA by segment as
follows:
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Net income (loss) |
|
$ |
126,786 |
|
|
$ |
(2,188 |
) |
|
$ |
(456 |
) |
|
$ |
(38,764 |
) |
|
$ |
85,378 |
|
Finance (income) expense,
net |
|
|
3,856 |
|
|
|
(9 |
) |
|
|
6 |
|
|
|
36,260 |
|
|
|
40,113 |
|
Current and deferred income tax
expense (recovery) |
|
|
41,300 |
|
|
|
— |
|
|
|
— |
|
|
|
(15,081 |
) |
|
|
26,219 |
|
Depreciation and depletion |
|
|
23,099 |
|
|
|
1,463 |
|
|
|
11 |
|
|
|
143 |
|
|
|
24,716 |
|
EBITDA |
|
$ |
195,041 |
|
|
$ |
(734 |
) |
|
$ |
(439 |
) |
|
$ |
(17,442 |
) |
|
|
176,426 |
|
Unrealized foreign exchange
(gain) loss |
|
|
— |
|
|
|
996 |
|
|
|
(332 |
) |
|
|
490 |
|
|
|
1,154 |
|
Share-based payment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,983 |
|
|
|
4,983 |
|
Transaction costs |
|
|
— |
|
|
|
— |
|
|
|
125 |
|
|
|
505 |
|
|
|
630 |
|
Gain on settlement |
|
|
(1,352 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,352 |
) |
Non-recurring compensation
expenses |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,511 |
|
|
|
1,511 |
|
Other income |
|
|
(8,343 |
) |
|
|
(328 |
) |
|
|
(20 |
) |
|
|
(33 |
) |
|
|
(8,724 |
) |
Adjusted EBITDA |
|
$ |
185,346 |
|
|
$ |
(66 |
) |
|
$ |
(666 |
) |
|
$ |
(9,986 |
) |
|
$ |
174,628 |
|
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Operating income (loss) |
|
$ |
163,688 |
|
|
$ |
(1,529 |
) |
|
$ |
(802 |
) |
|
$ |
(17,107 |
) |
|
$ |
144,250 |
|
Depreciation and depletion |
|
|
23,099 |
|
|
|
1,463 |
|
|
|
11 |
|
|
|
143 |
|
|
|
24,716 |
|
Realized foreign exchange
gain |
|
|
(89 |
) |
|
|
— |
|
|
|
— |
|
|
|
(21 |
) |
|
|
(110 |
) |
Share-based payment expense |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4,983 |
|
|
|
4,983 |
|
Transaction costs |
|
|
— |
|
|
|
— |
|
|
|
125 |
|
|
|
505 |
|
|
|
630 |
|
Gain on settlement |
|
|
(1,352 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,352 |
) |
Non-recurring compensation
expenses |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,511 |
|
|
|
1,511 |
|
Adjusted EBITDA |
|
$ |
185,346 |
|
|
$ |
(66 |
) |
|
$ |
(666 |
) |
|
$ |
(9,986 |
) |
|
$ |
174,628 |
|
As at September 30, 2023 and December
31, 2022
As at September 30, 2023, and December 31, 2022,
the Company had trailing 12 months Adjusted EBITDA as follows:
(unaudited in thousands of US Dollars) |
|
|
|
|
|
September 30, 2023 |
|
|
December 31, 2022 |
|
For the three months ended September 30, 2023 |
|
|
|
|
|
$ |
19,655 |
|
|
$ |
— |
|
For the three months ended June
30, 2023 |
|
|
|
|
|
|
39,677 |
|
|
|
— |
|
For the three months ended March
31, 2023 |
|
|
|
|
|
|
42,961 |
|
|
|
— |
|
For the three months ended
December 31, 2022 |
|
|
|
|
|
|
50,130 |
|
|
|
50,130 |
|
For the three months ended
September 30, 2022 |
|
|
|
|
|
|
— |
|
|
|
50,656 |
|
For the three months ended
June 30, 2022 |
|
|
|
|
|
|
— |
|
|
|
63,591 |
|
For the three months ended March
31, 2022 |
|
|
|
|
|
|
— |
|
|
|
60,381 |
|
Trailing 12 months Adjusted EBITDA |
|
|
|
|
|
$ |
152,423 |
|
|
$ |
224,758 |
|
TOTAL CAPEX
For the three months ended September 30,
2023 and 2022
For the three months ended September 30, 2023,
the Company had capex by segment as follows:
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Additions to
property, plant and equipment |
|
$ |
(8,090 |
) |
|
$ |
(23 |
) |
|
$ |
(1 |
) |
|
$ |
648 |
|
|
$ |
(7,466 |
) |
Additions to mineral properties |
|
|
10,097 |
|
|
|
— |
|
|
|
(6 |
) |
|
|
— |
|
|
|
10,091 |
|
Additions to property, plant and equipment related asset
retirement obligations |
|
|
13,757 |
|
|
|
244 |
|
|
|
— |
|
|
|
— |
|
|
|
14,001 |
|
Additions to right-of-use assets |
|
|
— |
|
|
|
(12 |
) |
|
|
1 |
|
|
|
(311 |
) |
|
|
(322 |
) |
Total capex |
|
$ |
15,764 |
|
|
$ |
209 |
|
|
$ |
(6 |
) |
|
$ |
337 |
|
|
$ |
16,304 |
|
Accrued capex |
|
|
1,079 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,079 |
|
Total cash
capex |
|
$ |
16,843 |
|
|
$ |
209 |
|
|
$ |
(6 |
) |
|
$ |
337 |
|
|
$ |
17,383 |
|
Maintenance capex |
|
$ |
2,795 |
|
|
$ |
94 |
|
|
$ |
— |
|
|
$ |
337 |
|
|
$ |
3,226 |
|
Accrued maintenance capex |
|
|
2,719 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,719 |
|
Cash
maintenance capex |
|
$ |
5,514 |
|
|
$ |
94 |
|
|
$ |
— |
|
|
$ |
337 |
|
|
$ |
5,945 |
|
Growth capex |
|
$ |
12,969 |
|
|
$ |
115 |
|
|
$ |
(6 |
) |
|
$ |
— |
|
|
$ |
13,078 |
|
Accrued growth capex |
|
|
(1,640 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,640 |
) |
Cash growth
capex |
|
$ |
11,329 |
|
|
$ |
115 |
|
|
$ |
(6 |
) |
|
$ |
— |
|
|
$ |
11,438 |
|
For the three months ended September 30, 2022,
the Company had capex by segment as follows:
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Additions to
property, plant and equipment |
|
$ |
6,216 |
|
|
$ |
120 |
|
|
$ |
— |
|
|
$ |
5 |
|
|
$ |
6,341 |
|
Additions to mineral properties |
|
|
2,239 |
|
|
|
— |
|
|
|
535 |
|
|
|
— |
|
|
|
2,774 |
|
Additions to property, plant and equipment related asset
retirement obligations |
|
|
(771 |
) |
|
|
332 |
|
|
|
— |
|
|
|
— |
|
|
|
(439 |
) |
Additions to right-of-use assets |
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
Total capex |
|
$ |
7,684 |
|
|
$ |
454 |
|
|
$ |
535 |
|
|
$ |
5 |
|
|
$ |
8,678 |
|
Accrued capex |
|
|
2,690 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,690 |
|
Total cash
capex |
|
$ |
10,374 |
|
|
$ |
454 |
|
|
$ |
535 |
|
|
$ |
5 |
|
|
$ |
11,368 |
|
Maintenance capex |
|
$ |
3,611 |
|
|
$ |
166 |
|
|
$ |
— |
|
|
$ |
5 |
|
|
$ |
3,782 |
|
Accrued maintenance capex |
|
|
3,169 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,169 |
|
Cash
maintenance capex |
|
$ |
6,780 |
|
|
$ |
166 |
|
|
$ |
— |
|
|
$ |
5 |
|
|
$ |
6,951 |
|
Growth capex |
|
$ |
4,073 |
|
|
$ |
288 |
|
|
$ |
535 |
|
|
$ |
— |
|
|
$ |
4,896 |
|
Accrued growth capex |
|
|
(479 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(479 |
) |
Cash growth
capex |
|
$ |
3,594 |
|
|
$ |
288 |
|
|
$ |
535 |
|
|
$ |
— |
|
|
$ |
4,417 |
|
For the nine months ended September 30,
2023 and 2022
For the nine months ended September 30, 2023,
the Company had capex by segment as follows:
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Additions to
property, plant and equipment |
|
$ |
2,050 |
|
|
$ |
194 |
|
|
$ |
24 |
|
|
$ |
657 |
|
|
$ |
2,925 |
|
Additions to mineral properties |
|
|
23,559 |
|
|
|
880 |
|
|
|
495 |
|
|
|
— |
|
|
|
24,934 |
|
Additions to asset retirement obligations |
|
|
9,799 |
|
|
|
(126 |
) |
|
|
— |
|
|
|
— |
|
|
|
9,673 |
|
Additions to right-of-use assets |
|
|
— |
|
|
|
8 |
|
|
|
(24 |
) |
|
|
(311 |
) |
|
|
(327 |
) |
Total capex |
|
$ |
35,408 |
|
|
$ |
956 |
|
|
$ |
495 |
|
|
$ |
346 |
|
|
$ |
37,205 |
|
Accrued capex |
|
|
(4,080 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(4,080 |
) |
Total cash capex |
|
$ |
31,328 |
|
|
$ |
956 |
|
|
$ |
495 |
|
|
$ |
346 |
|
|
$ |
33,125 |
|
Maintenance capex |
|
$ |
14,793 |
|
|
$ |
472 |
|
|
$ |
— |
|
|
$ |
346 |
|
|
$ |
15,611 |
|
Accrued maintenance capex |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Cash maintenance capex |
|
$ |
14,793 |
|
|
$ |
472 |
|
|
$ |
— |
|
|
$ |
346 |
|
|
$ |
15,611 |
|
Growth capex |
|
$ |
20,615 |
|
|
$ |
484 |
|
|
$ |
495 |
|
|
$ |
— |
|
|
$ |
21,594 |
|
Accrued growth capex |
|
|
(4,080 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(4,080 |
) |
Cash growth
capex |
|
$ |
16,535 |
|
|
$ |
484 |
|
|
$ |
495 |
|
|
$ |
— |
|
|
$ |
17,514 |
|
For the nine months ended September 30,
2022, the Company had capex by segment as follows:
(unaudited in thousands of US Dollars) |
|
Conda |
|
|
Arraias |
|
|
Development and exploration |
|
|
Corporate |
|
|
Total |
|
Additions to
property, plant and equipment |
|
$ |
23,959 |
|
|
$ |
2,419 |
|
|
$ |
— |
|
|
$ |
19 |
|
|
$ |
26,397 |
|
Additions to mineral properties |
|
|
4,866 |
|
|
|
— |
|
|
|
1,275 |
|
|
|
— |
|
|
|
6,141 |
|
Additions to asset retirement obligations |
|
|
(2,311 |
) |
|
|
(182 |
) |
|
|
— |
|
|
|
— |
|
|
|
(2,493 |
) |
Additions to right-of-use assets |
|
|
— |
|
|
|
(34 |
) |
|
|
— |
|
|
|
— |
|
|
|
(34 |
) |
Total capex |
|
$ |
26,514 |
|
|
$ |
2,203 |
|
|
$ |
1,275 |
|
|
$ |
19 |
|
|
$ |
30,011 |
|
Accrued capex |
|
|
(1,169 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,169 |
) |
Total cash capex |
|
$ |
25,345 |
|
|
$ |
2,203 |
|
|
$ |
1,275 |
|
|
$ |
19 |
|
|
$ |
28,842 |
|
Maintenance capex |
|
$ |
15,697 |
|
|
$ |
1,427 |
|
|
$ |
— |
|
|
$ |
19 |
|
|
$ |
17,143 |
|
Accrued maintenance capex |
|
|
(257 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(257 |
) |
Cash maintenance capex |
|
$ |
15,440 |
|
|
$ |
1,427 |
|
|
$ |
— |
|
|
$ |
19 |
|
|
$ |
16,886 |
|
Growth capex |
|
$ |
10,817 |
|
|
$ |
776 |
|
|
$ |
1,275 |
|
|
$ |
— |
|
|
$ |
12,868 |
|
Accrued growth capex |
|
|
(912 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(912 |
) |
Cash growth
capex |
|
$ |
9,905 |
|
|
$ |
776 |
|
|
$ |
1,275 |
|
|
$ |
— |
|
|
$ |
11,956 |
|
NET DEBT AND NET LEVERAGE
RATIO
As at September 30, 2023, and December 31, 2022,
the Company had net debt and net leverage ratio as follows:
(unaudited in thousands of US
Dollars |
|
September 30, |
|
|
December 31, |
|
except
as otherwise noted) |
|
2023 |
|
|
2022 |
|
Current debt |
|
$ |
29,130 |
|
|
$ |
29,217 |
|
Long-term debt |
|
|
68,631 |
|
|
|
98,907 |
|
Cash and cash equivalents |
|
|
(36,351 |
) |
|
|
(42,811 |
) |
Deferred financing costs related
to the Credit Facilities |
|
|
1,521 |
|
|
|
3,006 |
|
Net debt |
|
$ |
62,931 |
|
|
$ |
88,319 |
|
Trailing 12 months Adjusted
EBITDA |
|
$ |
152,423 |
|
|
$ |
224,758 |
|
Net leverage ratio |
|
0.4x |
|
|
0.4x |
|
LIQUIDITY
As at September 30, 2023, and December 31, 2022,
the Company had liquidity as follows:
|
|
September 30, |
|
|
December 31, |
|
(unaudited in thousands of US Dollars) |
|
2023 |
|
|
2022 |
|
Cash and cash equivalents |
|
$ |
36,351 |
|
|
$ |
42,811 |
|
ABL Facility undrawn borrowing
capacity |
|
|
40,000 |
|
|
|
21,447 |
|
Liquidity |
|
$ |
76,351 |
|
|
$ |
64,258 |
|
FREE CASH FLOW
For the three and nine months ended September
30, 2023 and 2022, the Company had free cash flow as follows:
|
|
For the three months ended September 30, |
|
|
For the nine months ended September 30, |
|
(unaudited in thousands of US Dollars) |
|
2023 |
|
2022 |
|
|
2023 |
|
2022 |
|
Cash flows from (used by) operating activities |
|
$ |
(3,771 |
) |
|
$ |
60,502 |
|
|
$ |
69,839 |
|
|
$ |
166,124 |
|
Cash flows used by investing
activities |
|
|
(17,383 |
) |
|
|
(11,368 |
) |
|
|
(33,126 |
) |
|
|
(28,841 |
) |
Less: Cash growth capex |
|
|
11,438 |
|
|
|
4,417 |
|
|
|
17,514 |
|
|
|
11,956 |
|
Free cash flow |
|
$ |
(9,716 |
) |
|
$ |
53,551 |
|
|
$ |
54,227 |
|
|
$ |
149,239 |
|
_________________________
1 Adjusted EBITDA, trailing 12 months
Adjusted EBITDA, maintenance capex, growth capex, net debt, net
leverage ratio and free cash flow are each a non-International
Financial Reporting Standards (“IFRS financial measure”). For
additional information on non-IFRS and other financial measures,
see “Non-IFRS financial measures” below.
2 Total capex is a non-IFRS financial measure. For
additional information on non-IFRS and other financial measures,
see “Non-IFRS financial measures” below.
3 Liquidity is a non-IFRS financial measure. For additional
information on non-IFRS and other financial measures, see “Non-IFRS
financial measures” below.
4 Timeline for H1/NDR based on management
estimates and subject to certain assumptions, including successful
permitting and development activities. The H1/NDR mine life
extension is based on a Preliminary Economic Assessment (“2019
PEA”) included in the Conda Technical Report (as defined below).
The 2019 PEA on the H1 and NDR properties is preliminary in nature
and includes inferred mineral resources that are considered too
speculative geologically to have the economic considerations
applied to them that would enable them to be categorized as mineral
reserves, and there is no certainty that the 2019 PEA will be
realized. Readers are referred to the Conda Technical Report for
the applicable qualifications and assumptions in connection with
its 2019 PEA.
Itafos (TSXV:IFOS)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Itafos (TSXV:IFOS)
Historical Stock Chart
Von Dez 2023 bis Dez 2024